CXCL8 and prostate carcinoma: However, blockade of IL-8 signalling via CXCR2 may be insufficient as IL-8 will continue to signal via CXCR1 that is also expressed on prostate cancer cells, stromal and immune cells within the mCRPC microenvironment [100].